RAIRDA’s statement on the 10-Year Health Plan for England
We welcome the Government’s focus on diagnosis in the new 10-Year Health Plan. Our Rare Care Matters report, produced in collaboration with Ipsos, shows that while...
Rare Care Matters: The struggle to access diagnosis and care for rare autoimmune rheumatic disease patients
Almost one-third of UK patients face a five-year wait for diagnosis. Today, the Rare Autoimmune Rheumatic Disease Alliance (RAIRDA) has launched a new report, revealing...
COVID-19 Seasonal Vaccination Programme: Autumn/winter 2024/25 – What people with RAIRDs need to know
The information on this webpage has been based on this summary from our member organisation Lupus UK. The NHS COVID-19 Seasonal Vaccination Programme: Autumn/winter 2024/25...
Email your local MP to speak up for people with rare autoimmune rheumatic conditions
In the light of the new Parliament, RAIRDA will continue to arrange meetings with, and promote our asks to, Members of Parliament and policymakers. RAIRDA’s...
RAIRDA Survey 2024 Participant Information Sheet
RAIRDA’s 2024 Manifesto
This Rare Disease Day, RAIRDA is excited to launch our 2024 manifesto, which highlights our key calls for the next UK Government. Our key calls...
Rare Disease Day: Update From Sue Farrington
As Rare Disease Day approaches on the 28th of February, it’s a great opportunity to reflect on our journey towards #ResettingtheBalance for RAIRDs, and the...
Briefing: A Quality Standard for Rare Disease
The Independent Advisory Group (IAG) to the forum on the UK Rare Diseases Framework is chaired by RAIRDA co-chair, Sue Farrington. The IAG has produced...
Vaccines Misconceptions Q and A
RAIRDA have produced a question and answer document to address misconceptions and common questions about COVID vaccinations for people with RAIRDs. The document is designed...
Resetting the Balance Report
The Rare Autoimmune Rheumatic Disease Alliance (RAIRDA) has released a report today highlighting ‘alarming disparities in the quality of care and treatment’ received by people...
Developing a Quality Standard for Rare Disease
RAIRDA is part of a working group exploring the development of a Quality Standard for Rare Disease, which will aim to improve the equity of...
Charities and clincians urge Government to secure Evusheld
Over 120 clinicians representing 17 different clinical specialities, across all 4 nations, have released a clinical consensus statement saying that there is sufficient evidence that...
This website uses only essential cookies to ensure functionality. These cookies are strictly necessary for the website to operate and do not track your browsing activity beyond the site.